DELTACYTOLYTICS

Welcome to the Brand page for “DELTACYTOLYTICS”, which is offered here for Pharmaceuticals, agents to treat cancer, autoimmunity, chronic viral infections, and other diseases characterized by abnormal cellular proliferation, and to improve tissue regeneration, wound healing, and transplantation;.

Its status is currently believed to be active. Its class is unavailable. “DELTACYTOLYTICS” is believed to be currently owned by “NEWELLINK USA, INC.”


Owner:
NEWELLINK USA, INC.
Owner Details
Description:
Pharmaceuticals, agents to treat cancer, autoimmunity, chronic viral infections, and other diseases characterized by abnormal cellular proliferation, and to improve tissue regeneration, wound healing, and transplantation;
Categories: PHARMACEUTICALS